Search

Your search keyword '"McDonald, Timothy J"' showing total 478 results

Search Constraints

Start Over You searched for: Author "McDonald, Timothy J" Remove constraint Author: "McDonald, Timothy J"
478 results on '"McDonald, Timothy J"'

Search Results

4. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study

5. Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits

6. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

7. Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

8. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study

9. Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

10. Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes.

12. The Association of Cardiometabolic, Diet and Lifestyle Parameters With Plasma Glucagon-like Peptide-1: An IMI DIRECT Study

14. Transdermal Blood Sampling for C-Peptide Is a Minimally Invasive, Reliable Alternative to Venous Sampling in Children and Adults With Type 1 Diabetes

18. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

19. Transdermal Blood Sampling for C-Peptide Is a Minimally Invasive, Reliable Alternative to Venous Sampling in Children and Adults With Type 1 Diabetes.

20. Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea‐treated KCNJ11 neonatal diabetes

21. Residual β-cell function is associated with longer time in range in individuals with type 1 diabetes

22. Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes

24. Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium

25. Whole blood co-expression modules associate with metabolic traits and type 2 diabetes: an IMI-DIRECT study

26. Cold-Flow Model Tests to Determine Static Performance of a NASA One-Sided Ejector Nozzle System

28. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

30. Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

33. Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes

35. Routine islet autoantibody testing in clinically diagnosed adult-onset type 1 diabetes can help identify misclassification and the possibility of successful insulin cessation.

38. Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics

39. Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic

41. Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 Diabetes.

43. Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study

45. Vaccine escape, increased breakthrough and reinfection in infliximab- treated patients with IBD during the Omicron wave of the SARSCoV- 2 pandemic.

50. Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab

Catalog

Books, media, physical & digital resources